# Riptide Therapeutics LLC

Canonical: https://abierto.us/vendors/riptide-therapeutics-llc-c95rhldbcvb9

- UEI: C95RHLDBCVB9
- CAGE: 97YF2
- Location: Evanston, IL
- Awards in window: 1 (6 transactions), $0 obligated, March 1, 2024 to January 14, 2026

## Awarding agencies

- National Institutes of Health: 1 awards, $0

## Industries

- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology): $0

## Competition

- Full and Open Competition After Exclusion of Sources: 1 awards

## Largest awards

- 75N91023C00035 (definitive contract): $0, NIH NCI. SBIR Topic #446 Phase I -Development of Senotherapeutic Agents for Cancer Treatment. https://www.usaspending.gov/award/CONT_AWD_75N91023C00035_7529_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/riptide-therapeutics-llc-c95rhldbcvb9.